Maintenance of infliximab treatment in ankylosing spondylitis: results of a one-year randomized controlled trial comparing systematic versus on-demand treatment.

Breban M, Ravaud P, Claudepierre P, Baron G, Henry YD, Hudry C, Euller-Ziegler L, Pham T, Solau-Gervais E, Chary-Valckenaere I, Marcelli C, Perdriger A, Le Loët X, Wendling D, Fautrel B, Fournié B, Combe B, Gaudin P, Jousse S, Mariette X, Baleydier A, Trape G, Dougados M, French Ankylosing Spondylitis Infliximab Network

Open source

DOI: 10.1002/art.23167
Published: 2008 Jan
Container: Arthritis and rheumatism
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/art.23167,
  title = {Maintenance of infliximab treatment in ankylosing spondylitis: results of a one-year randomized controlled trial comparing systematic versus on-demand treatment.},
  author = {Breban M and Ravaud P and Claudepierre P and Baron G and Henry YD and Hudry C and Euller-Ziegler L and Pham T and Solau-Gervais E and Chary-Valckenaere I and Marcelli C and Perdriger A and Le Loët X and Wendling D and Fautrel B and Fournié B and Combe B and Gaudin P and Jousse S and Mariette X and Baleydier A and Trape G and Dougados M and French Ankylosing Spondylitis Infliximab Network},
  year = {2008},
  journal = {Arthritis and rheumatism},
  doi = {10.1002/art.23167},
  url = {https://doi.org/10.1002/art.23167}
}

RIS

TY  - JOUR
TI  - Maintenance of infliximab treatment in ankylosing spondylitis: results of a one-year randomized controlled trial comparing systematic versus on-demand treatment.
AU  - Breban M
AU  - Ravaud P
AU  - Claudepierre P
AU  - Baron G
AU  - Henry YD
AU  - Hudry C
AU  - Euller-Ziegler L
AU  - Pham T
AU  - Solau-Gervais E
AU  - Chary-Valckenaere I
AU  - Marcelli C
AU  - Perdriger A
AU  - Le Loët X
AU  - Wendling D
AU  - Fautrel B
AU  - Fournié B
AU  - Combe B
AU  - Gaudin P
AU  - Jousse S
AU  - Mariette X
AU  - Baleydier A
AU  - Trape G
AU  - Dougados M
AU  - French Ankylosing Spondylitis Infliximab Network
PY  - 2008
JO  - Arthritis and rheumatism
DO  - 10.1002/art.23167
UR  - https://doi.org/10.1002/art.23167
ER  -

APA

M, B., P, R., P, C., G, B., YD, H., C, H., L, E., T, P., E, S., I, C., C, M., A, P., X, L. L., D, W., B, F., B, F., B, C., P, G., S, J., X, M., A, B., G, T., M, D., & Network, F. A. S. I. (2008). Maintenance of infliximab treatment in ankylosing spondylitis: results of a one-year randomized controlled trial comparing systematic versus on-demand treatment.. Arthritis and rheumatism. https://doi.org/10.1002/art.23167

Source records

pubmed · retrieved 2026-09-26T21:36:54.730Z